Heart failure – BJC TV https://tv.bjcardio.co.uk Short video updates for cardiologists Tue, 01 Sep 2026 14:15:32 +0000 en-GB hourly 1 https://wordpress.org/?v=7.1 https://tv.bjcardio.co.uk/wp-content/uploads/2023/06/cropped-favicon-32x32.png Heart failure – BJC TV https://tv.bjcardio.co.uk 32 32 BEACON series – Episode 1: Primary prevention of CVD – QRISK® <10% https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-1-primary-prevention-of-cvd-qrisk-10/ Tue, 01 Sep 2026 08:12:00 +0000 https://tv.bjcardio.co.uk/?p=11855 ® scores may underestimate their true risk. The faculty will examine how to identify patients who would benefit from earlier intervention, interpret lifetime versus 10-year cardiovascular risk, and optimise lipid-lowering and cardiovascular risk reduction strategies in line with current evidence and guidelines.]]> Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CVD = cardiovascular disease

]]> BEACON series – Episode 2: Secondary prevention post-MI and peripheral artery disease https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-2-secondary-prevention-post-mi-and-peripheral-artery-disease/ Tue, 01 Sep 2026 08:11:00 +0000 https://tv.bjcardio.co.uk/?p=11859 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; LDL-C = low-density lipoprotein cholesterol; MI = myocardial infarction

]]> BEACON series – Episode 3: CVD risk management in type 2 diabetes https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-3-cvd-risk-management-in-type-2-diabetes/ Tue, 01 Sep 2026 08:10:00 +0000 https://tv.bjcardio.co.uk/?p=11862 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CVD = cardiovascular disease

]]> BEACON series – Episode 4: Type 2 diabetes and chronic kidney disease https://tv.bjcardio.co.uk/cardiovascular-medicine/beacon-series-episode-4-type-2-diabetes-and-chronic-kidney-disease/ Tue, 01 Sep 2026 08:09:00 +0000 https://tv.bjcardio.co.uk/?p=11864 Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CKD = chronic kidney disease

]]> Heart failure in black patients – exploring genes and cardiac amyloidosis https://tv.bjcardio.co.uk/cardiovascular-medicine/heart-failure-in-black-patients-exploring-genes-and-cardiac-amyloidosis/ Wed, 22 Jul 2026 16:12:45 +0000 https://tv.bjcardio.co.uk/?p=11908

Learning objectives:

  • To understand the difference between Transthyretin Amyloidosis (ATTR) and Amyloid Light-chain Amyloidosis (AL)
  • To learn about the hereditary subtype ATTR V122I and how it affects patients of black ethnicity
  • To develop an understanding of the challenges faced in diagnosing and treating this condition
  • To gain awareness of ways to support black patients with hereditary ATTR and those who carry the gene
  • To feel empowered to diagnose ATTR and develop a knowledge of the condition to implement in clinical practise in a culturally sensitive way.

 

Speaker

Dr Jason Dungu PhD, FRCP, FESC

Consultant Cardiologist and Essex ICC Lead, Essex Cardiothoracic Centre, Mid & South Essex NHS Foundation Trust Honorary Senior Clinical Lecturer, Anglia Ruskin University 

]]> Insights from the ESC Heart Failure Congress, 2026 https://tv.bjcardio.co.uk/cardiovascular-medicine/insights-from-the-esc-heart-failure-congress-2026/ Fri, 15 May 2026 14:02:25 +0000 https://tv.bjcardio.co.uk/?p=11734

Learn more about some of the key sessions from the conference:

Cardiac amyloidosis: early diagnosis matters

Controversies in contemporary drug therapy for heart failure

How to crack the cardiorenal code: from clinical mastery to unit creation

Advances in cardiomyopathies

Debate: artificial intelligence in heart failure care, a great equaliser or a new divider?

Speaker

Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospital Dorset

 

]]> Living and dying well with heart failure – how can palliative care help? https://tv.bjcardio.co.uk/cardiovascular-medicine/living-and-dying-well-with-heart-failure-how-can-palliative-care-help/ Wed, 06 May 2026 09:35:23 +0000 https://tv.bjcardio.co.uk/?p=11670 Learning objectives:

  • To understand the potential role of palliative care in supporting heart failure patients
  • To learn about down titrating some medications to improve symptom control and reduce side effects 
  • To develop an understanding of advance care planning including DNACPR & ICD deactivation
  • To gain awareness of the ethical dilemmas that might arise
  • To feel inspired to develop relationships with your local palliative care providers and work together more closely

Speaker

Dr Sharon Chadwick, Consultant in Palliative Medicine, Hospice of St Francis, Berkhamsted, Hertfordshire

]]> Rapid up-titration of heart failure therapies: practice strategies for adopting a STRONG-HF pathway in the UK https://tv.bjcardio.co.uk/cardiovascular-medicine/rapid-up-titration-of-heart-failure-therapies-practice-strategies-for-adopting-a-strong-hf-pathway-in-the-uk/ Tue, 02 Dec 2025 16:10:12 +0000 https://tv.bjcardio.co.uk/?p=10794 1 pathway to improve heart failure care. They discuss early patient identification, rapid optimisation, and collaborative follow-up models tailored to local needs. Through shared learning and teamwork across disciplines, each centre has refined its approach to deliver more efficient, patient-centred heart failure management.]]> To learn more about STRONG-HF and NT-proBNP testing click here.

References
  1. Mebazaa A et al. Lancet 2022;400:1938–52

]]> Heart Failure Foundation Course: Managing renal function in people with heart failure with reduced ejection fraction https://tv.bjcardio.co.uk/renal-medicine/heart-failure-foundation-course-managing-renal-function-in-people-with-heart-failure-with-reduced-ejection-fraction/ Wed, 29 Oct 2025 15:27:50 +0000 https://tv.bjcardio.co.uk/?p=10344 Watch the full on-demand video and the other videos in this series on the Heart Failure Foundation Course 2025 resource site.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.

]]> Heart Failure Foundation Course: Optimising treatment for people with chronic heart failure with reduced ejection fraction https://tv.bjcardio.co.uk/featured-videos-1/heart-failure-foundation-course-optimising-treatment-for-people-with-chronic-heart-failure-with-reduced-ejection-fraction/ Wed, 29 Oct 2025 15:26:36 +0000 https://tv.bjcardio.co.uk/?p=10324 Watch the full on-demand video and the other videos in this series on the Heart Failure Foundation Course 2025 resource site.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report or alternatively email medinfo.uk@novartis.com or call 01276 698370.

]]>